1006-2963
2014 Issue 1
The relevance of serum aquaporin-4 antibody level with the clinical features of neuromyelitis optica
GAO Chun-li;,LI Ting;,QI Yuan;,WANG Jing;,YANG Chun-sheng;,YANG Li;,ZHANG Da-qi;
GAO Chun-li;,LI Ting;,QI Yuan;,WANG Jing;,YANG Chun-sheng;,YANG Li;,ZHANG Da-qi;
..............page:1-4
Study of prospective memory impairment in patients with myasthenia gravis
CAI Xiao-jie;,CHEN Hai-bo;,JIANG Yun;,LI Kai;,LI Shu-hua;,SU Wen;,ZHANG Hua;
CAI Xiao-jie;,CHEN Hai-bo;,JIANG Yun;,LI Kai;,LI Shu-hua;,SU Wen;,ZHANG Hua;
..............page:5-8
Prognostic factors of Guillain-Barré syndrome after intravenous immunoglobulin
CHEN Jie-ling;,HE Xue-tao;,LIU Wei-bin;,LIU Xin-tong;,WANG Li-juan;
CHEN Jie-ling;,HE Xue-tao;,LIU Wei-bin;,LIU Xin-tong;,WANG Li-juan;
..............page:9-11
Analysis of autonomic dysfunction and cognitive impairment in newly diagnosed Parkinson's disease
BI Yong;,CHEN Si-yan;,QI Fei-teng;,XIONG Ling-jie;,ZHANG Xu;,ZHANG Yang;
BI Yong;,CHEN Si-yan;,QI Fei-teng;,XIONG Ling-jie;,ZHANG Xu;,ZHANG Yang;
..............page:12-15
The clinical and radiological characteristics in 3 patients with reversible splenial lesion syndrome
HONG Dao-jun;,HUANG Zhao-jun;,LI Hui-hua;,WANG Bo;,WU Yu-chen;,ZHOU Mei-hong;
HONG Dao-jun;,HUANG Zhao-jun;,LI Hui-hua;,WANG Bo;,WU Yu-chen;,ZHOU Mei-hong;
..............page:16-19
Changes of IgG expression in substantia nigra par compacta of Parkinson's disease rats models
fu wen yu ;, liu zhi hui ;, liu zong zuo ;, sun yang ;, wang ming yu ;, wang xiao xiao ;, wang xin ;, yang tong ;, zhuang wen xin ;
fu wen yu ;, liu zhi hui ;, liu zong zuo ;, sun yang ;, wang ming yu ;, wang xiao xiao ;, wang xin ;, yang tong ;, zhuang wen xin ;
..............page:20-23
Clinical and imaging features of varicella-zoster virus myelitis (5 cases)
HU Bai;,LIU Wei;,WANG Juan;,WU Yuan-bo;,ZHU Yu-you;
HU Bai;,LIU Wei;,WANG Juan;,WU Yuan-bo;,ZHU Yu-you;
..............page:24-27
Clinical study on predicting value of hs-CRP combined with ABCD2 score in patients' progression from transient ischemic attack to cerebral infarction
DU Ji-chen;,WEI Heng;,YANG Xu;,YIN Hong-xiang;,YU Yong-fei;,ZHOU Rui;
DU Ji-chen;,WEI Heng;,YANG Xu;,YIN Hong-xiang;,YU Yong-fei;,ZHOU Rui;
..............page:28-31,35
Association between cystatin C and homocysteine level with carotid artery plaque stability
CHEN Guo-dong;,CHU Zhao-hu;,LIU Bing-rong;,XIAO Jin;
CHEN Guo-dong;,CHU Zhao-hu;,LIU Bing-rong;,XIAO Jin;
..............page:32-35
The genetic and skeletal muscle imaging characteristics of hypokalaemic periodic paralysis patients
GUO Xiu-hai;,JIA Bai-xue;,WANG Han;,YANG Qi;
GUO Xiu-hai;,JIA Bai-xue;,WANG Han;,YANG Qi;
..............page:36-40
Analysis of the risk factors leading to severe ischemic stroke
GONG Tao;,YANG Suo-suo;
GONG Tao;,YANG Suo-suo;
..............page:41-43
The effect of mild hypothermia on expression of apoptosis inducing factor following intracerebral hemorrhage
LI Xiao-ling;,WANG Man-xia;,YUAN Bo-yao;,ZHANG Bo;,ZHANG Shu-juan;,ZHANG Wen-jing;
LI Xiao-ling;,WANG Man-xia;,YUAN Bo-yao;,ZHANG Bo;,ZHANG Shu-juan;,ZHANG Wen-jing;
..............page:44-47
zhong zheng ji wu li feng xian dan he zuo suan duo tai xing yan jiu jin zhan
wang jian jian ;, wang li hua ;
wang jian jian ;, wang li hua ;
..............page:48-51
duo fa xing ying hua yi chuan xing yi gan ji yin ji biao da chan wu de yan jiu jin zhan
gao ya ran ;, gao yan jun ;, yu ning ;
gao ya ran ;, gao yan jun ;, yu ning ;
..............page:52-54
lingo ji yin yu pa jin sen bing he yuan fa xing zhen chan de xiang guan xing yan jiu jin zhan
ding jian qing ;, wang lei ;
ding jian qing ;, wang lei ;
..............page:54-57
kang n- jia ji -d- tian dong an suan shou ti nao yan de yan jiu jin zhan
liu lei ;, song zhao hui ;, wang jia wei ;
liu lei ;, song zhao hui ;, wang jia wei ;
..............page:58-62
xing xing jiao zhi xi bao zai ci ji su shen jing bao hu zhong de zuo yong
hu xue qiang ;, li rui ;
hu xue qiang ;, li rui ;
..............page:62-65
kang nmda shou ti nao yan san li
chen wei ;, zuo wen bo ;, hu xiang shu ;, li dan fang ;, li hua ;, ou yang mei ;, wu xin yan ;, xu shao qiang ;
chen wei ;, zuo wen bo ;, hu xiang shu ;, li dan fang ;, li hua ;, ou yang mei ;, wu xin yan ;, xu shao qiang ;
..............page:66-68
ji lan - ba lei zong he zheng yu zhong shu shen jing xi tong tuo sui qiao sun hai gong bing er li bao dao
qu xin hui ;, wu ling feng ;, wu xiao mu ;, xie xu fang ;, zhang kun nan ;
qu xin hui ;, wu ling feng ;, wu xiao mu ;, xie xu fang ;, zhang kun nan ;
..............page:68-69
shi shen jing ji sui yan he bing gan zao zong he zheng yi li
lin hang ;, wu lei ;, xu hai zhen ;
lin hang ;, wu lei ;, xu hai zhen ;
..............page:70-71
man xing te fa xing zhou suo xing zhou wei shen jing bing yi li
cao bing zhen ;, jin shan ;, li jing ;
cao bing zhen ;, jin shan ;, li jing ;
..............page:72-73
yi zi zhu shen jing gong neng sun hai wei zhu yao biao xian de duo fa xing ying hua yi li
cheng xiao juan ;, geng zhi ;, yao ji guo ;, zhao yu wu ;
cheng xiao juan ;, geng zhi ;, yao ji guo ;, zhao yu wu ;
..............page:74
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis
altintas a;,menge t;,teunissen c;, li hai feng ;
altintas a;,menge t;,teunissen c;, li hai feng ;
..............page:75
..............page:76